Summit Therapeutics Inc. (NASDAQ: SMMT) is experiencing a significant surge in its stock price, up 63% midday Monday, following the release of groundbreaking data from a key clinical trial. The stock, which closed at $12.27 on Friday, opened at $16 and has been...
A recent investigation by the Associated Press has unveiled a troubling oversight in the regulation of pharmaceutical manufacturing plants by the U.S. Food and Drug Administration (FDA). According to their analysis, nearly half of the drug manufacturing facilities...
Inflation in the United States rose to 2.4% in September, according to the latest report from the Bureau of Labor Statistics (BLS). This figure represents a 0.2% increase in the consumer price index (CPI) for the month, slightly surpassing the Dow Jones consensus...
Delta Air Lines (DAL) experienced a significant decline in its share price following the release of its third-quarter earnings report, which failed to meet analysts’ expectations. The airline posted adjusted earnings per share (EPS) of $1.50 on revenue of $15.68...
In a promising turn of events for investors, stocks rallied significantly after Nvidia extended its impressive five-day rally to 13%. This surge comes as part of a broader recovery for the market, following its worst session in a month. The positive momentum was...